English
简体中文
Total: £ 56.28
Published Date: 2024-12-04 | Pages: 98 | Tables: 208 | Pharma & Healthcare
The global market for Drugs For Travelers' Diarrhea (TD) was estimated to be worth US$ 1326 million in 2023 and is forecast to a readjusted size of US$ 1808.7 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs For Travelers' Diarrhea (TD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drugs For Travelers' Diarrhea (TD) by region & country, by Type, and by Application.
The Drugs For Travelers' Diarrhea (TD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs For Travelers' Diarrhea (TD).
Market Segmentation
By Company
Johnson & Johnson
Bausch Health Companies Inc.
COSMO PHARMACEUTICALS
Immuron
Valneva SE
Sun Pharmaceutical Industries Ltd.
Norgine
Perrigo Company Plc
Bayer AG
Segment by Type:
Oral Rehydration Therapy (ORS)
Antidiarrheal Agents
Antibiotics
Others
Segment by Application
Adults
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drugs For Travelers' Diarrhea (TD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Drugs For Travelers' Diarrhea (TD) Product Introduction
1.2 Global Drugs For Travelers' Diarrhea (TD) Market Size Forecast
1.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030)
1.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume (2019-2030)
1.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Price (2019-2030)
1.3 Drugs For Travelers' Diarrhea (TD) Market Trends & Drivers
1.3.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
1.3.2 Drugs For Travelers' Diarrhea (TD) Market Drivers & Opportunity
1.3.3 Drugs For Travelers' Diarrhea (TD) Market Challenges
1.3.4 Drugs For Travelers' Diarrhea (TD) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Drugs For Travelers' Diarrhea (TD) Players Revenue Ranking (2023)
2.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (2019-2024)
2.3 Global Drugs For Travelers' Diarrhea (TD) Players Sales Volume Ranking (2023)
2.4 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company Players (2019-2024)
2.5 Global Drugs For Travelers' Diarrhea (TD) Average Price by Company (2019-2024)
2.6 Key Manufacturers Drugs For Travelers' Diarrhea (TD) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Drugs For Travelers' Diarrhea (TD) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Drugs For Travelers' Diarrhea (TD)
2.9 Drugs For Travelers' Diarrhea (TD) Market Competitive Analysis
2.9.1 Drugs For Travelers' Diarrhea (TD) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Drugs For Travelers' Diarrhea (TD) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs For Travelers' Diarrhea (TD) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Rehydration Therapy (ORS)
3.1.2 Antidiarrheal Agents
3.1.3 Antibiotics
3.1.4 Others
3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type
3.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Type (2019-2030)
3.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Type (%) (2019-2030)
3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type
3.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Type (2019-2030)
3.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Type (%) (2019-2030)
3.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application
4.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Application (2019-2030)
4.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Application (%) (2019-2030)
4.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application
4.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Application (2019-2030)
4.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Application (%) (2019-2030)
4.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region
5.1.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024)
5.1.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030)
5.1.4 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (%), (2019-2030)
5.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region
5.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024)
5.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030)
5.2.4 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (%), (2019-2030)
5.3 Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
5.4.2 North America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
5.5.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
5.6.2 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
5.7.2 South America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
5.8.2 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value
6.2.1 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.3.2 United States Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.4.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.5.2 China Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.6.2 Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.7.2 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.8.2 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
6.9.2 India Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Information
7.1.2 Johnson & Johnson Introduction and Business Overview
7.1.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Offerings
7.1.5 Johnson & Johnson Recent Development
7.2 Bausch Health Companies Inc.
7.2.1 Bausch Health Companies Inc. Company Information
7.2.2 Bausch Health Companies Inc. Introduction and Business Overview
7.2.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Offerings
7.2.5 Bausch Health Companies Inc. Recent Development
7.3 COSMO PHARMACEUTICALS
7.3.1 COSMO PHARMACEUTICALS Company Information
7.3.2 COSMO PHARMACEUTICALS Introduction and Business Overview
7.3.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Offerings
7.3.5 COSMO PHARMACEUTICALS Recent Development
7.4 Immuron
7.4.1 Immuron Company Information
7.4.2 Immuron Introduction and Business Overview
7.4.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Offerings
7.4.5 Immuron Recent Development
7.5 Valneva SE
7.5.1 Valneva SE Company Information
7.5.2 Valneva SE Introduction and Business Overview
7.5.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Offerings
7.5.5 Valneva SE Recent Development
7.6 Sun Pharmaceutical Industries Ltd.
7.6.1 Sun Pharmaceutical Industries Ltd. Company Information
7.6.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
7.6.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Offerings
7.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
7.7 Norgine
7.7.1 Norgine Company Information
7.7.2 Norgine Introduction and Business Overview
7.7.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Offerings
7.7.5 Norgine Recent Development
7.8 Perrigo Company Plc
7.8.1 Perrigo Company Plc Company Information
7.8.2 Perrigo Company Plc Introduction and Business Overview
7.8.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Offerings
7.8.5 Perrigo Company Plc Recent Development
7.9 Bayer AG
7.9.1 Bayer AG Company Information
7.9.2 Bayer AG Introduction and Business Overview
7.9.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Offerings
7.9.5 Bayer AG Recent Development
8 Industry Chain Analysis
8.1 Drugs For Travelers' Diarrhea (TD) Industrial Chain
8.2 Drugs For Travelers' Diarrhea (TD) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Drugs For Travelers' Diarrhea (TD) Sales Model
8.5.2 Sales Channel
8.5.3 Drugs For Travelers' Diarrhea (TD) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Drugs For Travelers' Diarrhea (TD) Market Trends
Table 2. Drugs For Travelers' Diarrhea (TD) Market Drivers & Opportunity
Table 3. Drugs For Travelers' Diarrhea (TD) Market Challenges
Table 4. Drugs For Travelers' Diarrhea (TD) Market Restraints
Table 5. Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Company (2019-2024)
Table 7. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Drugs For Travelers' Diarrhea (TD) Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Drugs For Travelers' Diarrhea (TD) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Drugs For Travelers' Diarrhea (TD) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Drugs For Travelers' Diarrhea (TD)
Table 13. Global Drugs For Travelers' Diarrhea (TD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs For Travelers' Diarrhea (TD) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024) & (%)
Table 44. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030) & (%)
Table 45. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, (2025-2030) & (K Units)
Table 57. Johnson & Johnson Company Information
Table 58. Johnson & Johnson Introduction and Business Overview
Table 59. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 61. Johnson & Johnson Recent Development
Table 62. Bausch Health Companies Inc. Company Information
Table 63. Bausch Health Companies Inc. Introduction and Business Overview
Table 64. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 66. Bausch Health Companies Inc. Recent Development
Table 67. COSMO PHARMACEUTICALS Company Information
Table 68. COSMO PHARMACEUTICALS Introduction and Business Overview
Table 69. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 71. COSMO PHARMACEUTICALS Recent Development
Table 72. Immuron Company Information
Table 73. Immuron Introduction and Business Overview
Table 74. Immuron Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Immuron Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 76. Immuron Recent Development
Table 77. Valneva SE Company Information
Table 78. Valneva SE Introduction and Business Overview
Table 79. Valneva SE Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Valneva SE Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 81. Valneva SE Recent Development
Table 82. Sun Pharmaceutical Industries Ltd. Company Information
Table 83. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 84. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 86. Sun Pharmaceutical Industries Ltd. Recent Development
Table 87. Norgine Company Information
Table 88. Norgine Introduction and Business Overview
Table 89. Norgine Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Norgine Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 91. Norgine Recent Development
Table 92. Perrigo Company Plc Company Information
Table 93. Perrigo Company Plc Introduction and Business Overview
Table 94. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 96. Perrigo Company Plc Recent Development
Table 97. Bayer AG Company Information
Table 98. Bayer AG Introduction and Business Overview
Table 99. Bayer AG Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Bayer AG Drugs For Travelers' Diarrhea (TD) Product Offerings
Table 101. Bayer AG Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Drugs For Travelers' Diarrhea (TD) Downstream Customers
Table 105. Drugs For Travelers' Diarrhea (TD) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs For Travelers' Diarrhea (TD) Product Picture
Figure 2. Global Drugs For Travelers' Diarrhea (TD) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Drugs For Travelers' Diarrhea (TD) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Drugs For Travelers' Diarrhea (TD) Sales Price (2019-2030) & (US$/Unit)
Figure 6. Drugs For Travelers' Diarrhea (TD) Report Years Considered
Figure 7. Global Drugs For Travelers' Diarrhea (TD) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Drugs For Travelers' Diarrhea (TD) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs For Travelers' Diarrhea (TD) Revenue in 2023
Figure 10. Drugs For Travelers' Diarrhea (TD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Rehydration Therapy (ORS) Picture
Figure 12. Antidiarrheal Agents Picture
Figure 13. Antibiotics Picture
Figure 14. Others Picture
Figure 15. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Adults
Figure 21. Product Picture of Children
Figure 22. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume (%), (2019-2030)
Figure 39. United States Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 45. China Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 47. China Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 57. India Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
Figure 59. India Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
Figure 60. Drugs For Travelers' Diarrhea (TD) Industrial Chain
Figure 61. Drugs For Travelers' Diarrhea (TD) Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
